BIONEUTRAL

BIO FCF Yield Analysis

3.9%

Higher than 59% of Healthcare sector peers

Updated 300h ago·SEC filings & market data

Key Takeaway

Free cash flow yield (FCF yield) measures the cash a company generates relative to its market value; Bio-Rad’s current 3.9% means it produces $0.039 of free cash flow per dollar of equity value.

Sector Performance

59th percentile

BIO

3.9%

Sector Median

3.4%

Sector Avg

-16.2%

Prior Period

4.2%(Jul 2026)

↓ Declining
📊

Deep Analysis

Free cash flow yield (FCF yield) measures the cash a company generates relative to its market value; Bio-Rad’s current 3.9% means it produces $0.039 of free cash flow per dollar of equity value.

That sits above the healthcare sector median of 3.4%, placing Bio-Rad in the 59th percentile of sector peers. The year-over-year change is N/A, but quarter-over-quarter the metric fell 7.1%, from 4.2% to 3.9%, so the trend direction over the last 8 quarters is also N/A. The combination of a yield above the peer median but a recent quarterly decline suggests moderate cash generation with recent slippage, implying some short-term pressure but no acute cash-flow crisis. This metric broadly supports the NEUTRAL verdict: it is neither exceptionally high nor dangerously low relative to peers, and the small recent drop tempers the positive level.

Frequently Asked Questions

What does the FCF Yield tell investors about BIO?

One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.

How is the FCF Yield calculated?

FCF Yield is calculated as: Free Cash Flow / Market Cap.

How does BIO's FCF Yield compare to its sector?

BIO's FCF Yield of 3.9% compares to a Healthcare sector median of 3.4%, placing it in the 59th percentile.

Who are BIO's closest peers by FCF Yield?

The closest Healthcare peers by FCF Yield include: ABT (3.4%), CAH (3.3%), A (2.8%), RVTY (4.2%), ALGN (4.3%).

The Formula

Free Cash Flow / Market Cap

Why It Matters

One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.

Advertisement

Master BIO's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BIO research report

Free account — no credit card

BIO

3.9%

Sector Median

3.4%

Sector Avg

-16.2%

How BIO's FCF Yield compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.